Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

8,828

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

8,828 results for “product”

Learn how ShareScore rates datasets ↗
zenodo40/100

Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - The Czech Republic

<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of The Czech Republic. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 &ndash; State Veterinary Administration - Ministry of Agriculture</p> <p>VMPR_2022 &ndash; State Veterinary Administration - Ministry of Agriculture; National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2021 &ndash; State Veterinary Administration - Ministry of Agriculture; National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2020&nbsp;&ndash;&nbsp;State Veterinary Administration - Ministry of Agriculture;&nbsp;National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2019&nbsp;&ndash;&nbsp;State Veterinary Administration - Ministry of Agriculture;&nbsp;National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2018 &ndash;&nbsp;State Veterinary Administration - Ministry of Agriculture;&nbsp;National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2017&nbsp;&ndash;&nbsp;State Veterinary Administration - Ministry of Agriculture</p>

opencc-by-4.0Mar 2020View details →
zenodo40/100

Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Bulgaria

<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Bulgaria. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. &nbsp;Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 &ndash; Central Laboratory for Veterinary Sanitary Expertise and Ecology within the Bulgarian Food Safety Agency</p> <p>VMPR_2022 &ndash; Central Laboratory for Veterinary Sanitary Expertise and Ecology within the Bulgarian Food Safety Agency</p> <p>VMPR_2021 &ndash; Central Laboratory for Veterinary Sanitary Expertise and Ecology within the Bulgarian Food Safety Agency</p> <p>VMPR_2020&nbsp;&ndash;&nbsp;Central Laboratory for Veterinary Sanitary Expertise and Ecology&nbsp;within the Bulgarian Food Safety Agency</p> <p>VMPR_2019 &ndash;&nbsp;Risk Assessment Center on Food Chain</p> <p>VMPR_2018 &ndash;&nbsp;Bulgarian Food Safety Agency</p> <p>VMPR_2017&nbsp;&ndash;&nbsp;Bulgarian Food Safety Agency</p>

opencc-by-4.0Feb 2022View details →
zenodo40/100

Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Hungary

<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Hungary. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. &nbsp;Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 &ndash; National Food Chain Safety Office</p> <p>VMPR_2022 &ndash; National Food Chain Safety Office</p> <p>VMPR_2021 &ndash; National Food Chain Safety Office</p> <p>VMPR_2020&nbsp;&ndash;&nbsp;National Food Chain Safety Office</p> <p>VMPR_2019&nbsp;&ndash;&nbsp;National Food Chain Safety Office</p> <p>VMPR_2018 &ndash;&nbsp;National Food Chain Safety Office</p> <p>VMPR_2017&nbsp;&ndash;&nbsp;National Food Chain Safety Office</p>

opencc-by-4.0May 2019View details →
zenodo40/100

Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Sweden

<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Sweden. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. &nbsp;Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 &ndash; National Food Agency</p> <p>VMPR_2022 &ndash; National Food Agency</p> <p>VMPR_2021 &ndash; National Food Agency</p> <p>VMPR_2020&nbsp;&ndash;&nbsp;National Food Agency</p> <p>VMPR_2019&nbsp;&ndash;&nbsp;National Food Agency</p> <p>VMPR_2018 &ndash;&nbsp;National Food Agency</p> <p>VMPR_2017&nbsp;&ndash;&nbsp;National Food Agency</p>

opencc-by-4.0May 2019View details →
zenodo40/100

Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Lithuania

<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Lithuania. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. &nbsp;Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 &ndash; National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2022 &ndash; National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2021 &ndash; National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2020&nbsp;&ndash;&nbsp;National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2019&nbsp;&ndash;&nbsp;National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2018 &ndash;&nbsp;National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2017&nbsp;&ndash;&nbsp;National Food and Veterinary Risk Assessment Institute</p>

opencc-by-4.0May 2019View details →
zenodo40/100

Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Spain

<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Spain. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 &ndash; Spanish Agency for Food Safety and Nutrition; Ministry of Health</p> <p>VMPR_2022 &ndash; Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2021 &ndash; Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2020&nbsp;&ndash;&nbsp;Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2019&nbsp;&ndash;&nbsp;Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2018 &ndash;&nbsp;Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2017&nbsp;&ndash;&nbsp;Spanish Agency for Food Safety and Nutrition; Ministry of Agriculture and Fisheries, Food and Environment</p>

opencc-by-4.0Mar 2020View details →
zenodo40/100

Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Germany

<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Germany. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 &ndash; Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2022 &ndash; Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2021 &ndash; Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2020&nbsp;&ndash;&nbsp;Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2019&nbsp;&ndash;&nbsp;Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2018 &ndash;&nbsp;Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2017&nbsp;&ndash;&nbsp;Federal Office of Consumer Protection and Food Safety</p>

opencc-by-4.0May 2019View details →
zenodo40/100

Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - United Kingdom in respect of Northern Ireland

<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of United Kingdom in respect of Northern Ireland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p>For 2021 and 2022 the only United Kingdom data that were reported to EFSA were from Northern Ireland. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Irelandfrom the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the WindsorFramework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee establishedby the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the EuropeanUnion and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p.87) in conjunction withsection 24 of Annex 2 to that Framework, for the purposes of this Regulation, references to Member States include theUnited Kingdom in respect of Northern Ireland.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 &ndash; Department of Agriculture, Environment and Rural Affairs</p> <p>VMPR_2022 &ndash; Department of Agriculture, Environment and Rural Affairs</p> <p>VMPR_2021&nbsp;&ndash;&nbsp;Department of Agriculture, Environment and Rural Affairs</p>

opencc-by-4.0Feb 2023View details →
zenodo40/100

A monthly 5 km Arctic sea ice thickness product from 1995 to 2023 using multiple radar altimetry data

<p>Arctic sea ice is of great importance to the regional and global climate change study. Satellite observations have demonstrated that the Arctic sea ice extent has been declined for the last four decades. However, long-term variations of the Arctic sea ice thickness (SIT) are less focused as SIT cannot be measured directly by satellite-based instruments. Here, we presented a monthly Arctic SIT product based on multiple radar altimetry observations from ERS-2, Envisat, and CryoSat-2. To ensure the accuracy of the SIT retrievals, we proposed a novel data processing procedure including leads detection, freeboard conversion to thickness and inter-mission bias correction. Finally, we were able to generate the monthly SIT estimates for the Arctic Ocean from October 1995 to December 2023. The thickness estimates are posted on a 5 km resolution polar stereographic grid. The variations of the Arctic SIT are analyzed in terms of the spatial and temporal distributions. We also compared our SIT estimates with observations from upward looking sonars (ULSs) and airborne laser altimetry from Operation IceBridge (OIB), as well as seven publicly released Arctic SIT products. The validation results demonstrate that our SIT product features equivalent accuracy with existing products. The accuracy of our products is about 0.4 m during Envisat period, and is within 0.2 m during CryoSat-2 period.</p>

opencc-by-4.0Dec 2023View details →
zenodo40/100

Data supporting "A comprehensive analysis of air-sea CO2 flux uncertainties constructed from surface ocean data products"

<p>Changelog</p> <p>v2: Fixes an identified issue in FluxEngine v4.0.7 that affects the calculation of fCO2atm. Fluxes have been recalculated using FluxEngine v4.0.9.1, and the analysis regenerated. The intergrated air-sea CO2 flux (or ocean sink) has reduced by ~0.2-0.3Pg C yr-1 but uncertainties are unchanged.&nbsp;</p> <p>v1: Initial dataset released along with the supporting manuscript</p> <p>&nbsp;</p> <p>Data included in this repository supports the manuscript "A comprehensive analysis of air-sea CO<sub>2</sub> flux uncertainties constructed from surface ocean data products".</p> <p>Two files are present:</p> <ol> <li>A Python config file used to run the software developed for the analysis (Ford et al., 2024)</li> <li>A ZIP file containing the input, neural network, and output files for the analysis.</li> </ol> <p>Within the ZIP file, multiple folders are present:</p> <ol> <li>Decorrelation contains .csv files that contain the annual estimates of the decorrelation lengths for the parameters requiring these (SST, sea ice, wind, fCO<sub>2</sub> and fCO<sub>2</sub> network).</li> <li>Flux contains the individual FluxEngine output files that provide all the flux calculations, and auxillary data to the flux calculations.</li> <li>Fluxengine_input contains the input files to FluxEngine, which specifies the fCO<sub>2 (sw), </sub>xCO<sub>2 (atm)</sub> and the temperature, salinities for the skin and subskin layers.</li> <li>Inputs contains all the monthly 1 degree input data used. Many of the data used are not native monthly 1 deg, and so these are generated from the higher resolution data. These are all combined into the neural_network_input.nc file, so a single file can be distributed with all the inputs used.</li> <li>Networks contains the TensorFlow neural network (FNN) files, where each province has 10 folders (one for each ensemble).</li> <li>Plots contains output plots for debugging and final plots of uncertainties</li> <li>Scalars contains the scalars used to normalise the data before input into the neural network. These are saved as Python pickle files, as they are needed if the neural network is used on other data.</li> <li>Unc_lut contains the look up tables to generate the parameter uncertainty as described in the manuscript. These are Python pickle files.</li> <li>Validation contains a csv file with the independent test RMSD, along with Python Pickle files of the validation data.</li> </ol> <p>In the main folder, three files are present:</p> <ol> <li>Annual_flux.csv contains the annual air-sea CO<sub>2</sub> flux (or ocean sink estimate) estimated from the fCO<sub>2 (sw)</sub> fields. This also contains the annual integrated uncertainties for each component in the uncertainty flow chart in the manuscript.</li> <li>Output.nc contrains the gridded global fields of the fCO<sub>2 (sw)</sub>, the air-sea CO<sub>2</sub> flux, and the uncertainties for all the individual components. Metadata within the file should provide all the information required.</li> <li>Training.tsv contains the training/validation data alongside the input parameters for neural network training</li> </ol> <p>&nbsp;</p> <p>Please contact Daniel J. Ford (<a href="mailto:d.ford@exeter.ac.uk">d.ford@exeter.ac.uk</a>) if you have any questions.</p> <p><strong>Acknowledgements</strong></p> <p>This work was funded by the Convex Seascape Survey (https://convexseascapesurvey.com/) and the European Union under grant agreement no. 101083922 (OceanICU; https://ocean-icu.eu/) and UK Research and Innovation (UKRI) under the UK government&rsquo;s Horizon Europe funding guarantee [grant number 10054454, 10063673, 10064020, 10059241, 10079684, 10059012, 10048179]. The views, opinions and practices used to produce this dataset/software are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.</p> <p>The Surface Ocean CO₂ Atlas (SOCAT) is an international effort, endorsed by the International Ocean Carbon Coordination Project (IOCCP), the Surface Ocean Lower Atmosphere Study (SOLAS) and the Integrated Marine Biosphere Research (IMBeR) program, to deliver a uniformly quality-controlled surface ocean CO₂ database. The many researchers and funding agencies responsible for the collection of data and quality control are thanked for their contributions to SOCAT.</p> <p>&nbsp;</p> <p><strong>References</strong></p> <p>Ford, D. J., Blannin, J., Watts, J., Watson, A. J., Landschutzer, P., Jersild, A., &amp; Shutler, J. D. (2024, June 30). OceanICU Neural Network Framework with per pixel uncertainty propagation (v1.1) (Version v1.1). Zenodo. https://doi.org/10.5281/ZENODO.12597803</p>

opencc-by-4.0Oct 2024View details →
zenodo40/100

GLC_FCS30D: the first global 30-m land-cover dynamic monitoring product with fine classification system from 1985 to 2022

<div> <p>GLC_FCS30D is the first global fine land cover dynamic product at a 30-meter resolution that adopts continuous change detection. It utilizes a refined classification system containing 35 land-cover categories and covers the time span from 1985 to 2022. Before the year 2000, the update cycle was every 5 years, while after 2000, it is updated annually. In specific, it developed by combining the continuous change detection method, local adaptive updating models and the spatiotemporal optimization algorithm from dense time-series Landsat imagery, and was validated to achieve an overall accuracy of 80.88% (&plusmn;0.27%) for the basic classification system 10 major land-cover types) and 73.24% (&plusmn;0.30%) for the LCCS level-1 validation system (17 LCCS land-cover types).</p> <p>The GLC_FCS30D has been compressed into 36 zip files, and<strong> <em>the details about the GLC_FCS30D can be found in the User's guides.</em></strong></p> </div>

opencc-by-4.0Aug 2023View details →
zenodo40/100

The key role of production efficiency changes in livestock methane emission mitigation

<p>This dataset contains the R code, the input data, the parameters used, and the updated livestock methane emission for the period 1961-2023 using methods from Chang, J., Peng, S., Yin, Y., Ciais, P., Havlik, P., Herrero, M. (2021). The key role of production efficiency changes in livestock methane emission mitigation. AGU Advances, 2, e2021AV000391. DOI: https://doi. org/10.1029/2021AV000391&nbsp;</p> <p>1. R code: Chang_et_al_Global_Livestock_CH4_Assessment_1961_2023.R<br>2. Input data and parameters: Data.zip (statistics on historical livestock numbers and production need to be downloaded from FAOSTAT (http://www.fao.org/faostat/en/)<br>3. Results on global livestock methane emissions during 1961-2023 were presented in the Global_Results.xlsx<br>4. Results on livestock methane emissions from enteric fermentation and manure management during the period 1961-2023 in each country/area were shown in the folder named Country_Results: Files are organized as "Country_[XX]CH4_[YY]_[ZZ].csv" where XX indicate emission from enteric fermentation (EF) or manure management (MM); YY indicates method used for the estimates; and ZZ indicates livestock categories.<br>5. Results on gridded livestock methane emissions at a resolution of 5 arc-min using the IPCC Mixed Tier 1 and Tier 2 (2019MT) and Tier 1 (2019T1) methods following the 2019 refinement to the 2006 IPCC guidelines for National Greenhouse Gas Inventories (Vol. 4) (IPCC, 2019): Livestock_CH4_map_5arcmin_1961_2023_2019MT_2019T1.nc4</p> <p>Please contact: Dr. Jinfeng Chang&nbsp;(changjf@zju.edu.cn) for any question on the&nbsp;dataset.</p>

opencc-by-4.0Apr 2021View details →
zenodo40/100

Plankton community composition and productivity near the Subantarctic Prince Edward Islands archipelago in autumn

<p>This data set, shows hydrographic (CTD) and biogeochemical (Chl-a, nitrate+nitrite, nitrite, ammonium and silicic acid&nbsp;concentrations)&nbsp;parameters,&nbsp;nitrate uptake rates and net primary production, egg production rates (<em>Calanus simillimus)</em>, Pheophytin-a concentrations in zooplankton guts, and phytoplankton and zooplankton abundances and biomass&nbsp;from the&nbsp;Prince Edward Islands archipelago in the Indian Sector of the Subantarctic&nbsp;Ocean, during April-May 2017.</p> <p>&nbsp;</p>

opencc-by-4.0Aug 2021View details →
zenodo40/100

Els 20 productes més venuts a Ziicube

<p>Relaci&oacute; dels 20 productes m&eacute;s venuts, els &uacute;ltims trenta dies,&nbsp;a&nbsp;la web del portal de venda de cubs de Rubik&nbsp;<a href="https://www.ziicube.com/">ziicube</a>.</p> <p>Cada producte t&eacute; els&nbsp;seg&uuml;ents atributs:</p> <ul> <li><em><strong>pos</strong></em>: Posici&oacute; en el r&agrave;rquing dels m&eacute;s venuts</li> <li><em><strong>id</strong></em>: Codi d&#39;identificaci&oacute; del producte</li> <li><em><strong>name</strong></em>: Nom del producte</li> <li><em><strong>price</strong></em>: Preu del producte en $</li> <li><em><strong>rat</strong></em>: Valoraci&oacute; del producte per part dels consumidors (0-100)</li> <li><em><strong>likes</strong></em>: N&uacute;mero de m&#39;agrades que ha rebut el producte</li> <li><em><strong>brand_name</strong></em>: Nom de l&#39;empresa que produeix el producte</li> <li><em><strong>web</strong></em>: P&agrave;gina web del producte</li> </ul>

opencc-by-nc-4.0Nov 2021View details →
zenodo40/100

Proximitat de productes venuts a Bonpreu-Esclat

<p>El <em>dataset</em> presenta la relaci&oacute; dels productes disponibles a la plataforma de compra <em>online</em> de la cadena de distribuci&oacute;<strong> Bonpreu-Esclat</strong> (Catalunya, Espanya), que han estat recopilats amb t&egrave;cniques de <em>web scraping</em>.</p> <p>Apart de la data d&#39;extracci&oacute;, inclou les dades seg&uuml;ents: categoria, nom de producte, format de l&rsquo;env&agrave;s, preu, preu per volum, informaci&oacute; del producte, marca, adre&ccedil;a del prove&iuml;dor, latitud del prove&iuml;dor, longitud del prove&iuml;dor,&nbsp; ingredients, dades nutricionals i instruccions.</p> <p>Cal destacar que, at&egrave;s que es facilita la geoposici&oacute; del prove&iuml;dor del producte (latitud i longitud), aix&ograve; permet posicionar-lo en un mapa i tamb&eacute; calcular la dist&agrave;ncia entre productor i comprador. D&#39;aquesta manera es poden fer an&agrave;lisis de proximitat dels productes, arribant a identificar aquells que hom consideri <em>productes de quil&ograve;metre zero</em>.</p>

opencc-by-4.0Nov 2021View details →
zenodo40/100

Upcycling food ingredients from orange by-products by hot air-microwave drying. Impact on energy consumption.

<p>Currently industrial citrus by-products represent a relevant environmental issue. The main aim of this work was the chemical characterization of the different bioactive compounds obtained after hot air-microwave drying (HAD+MW) of orange by-products, and their further conversion into three <strong>upcycled </strong>ingredients with health-related benefits: aqueous extract, ethanolic extract and <strong>dietary fibre</strong>. Total phenolics, antioxidant capacity, individual phenolic acids, flavonoids, limonin and carotenoids were monitored during blanching and colour extraction steps by analysing fresh by-products and process co-products: an aqueous extract rich in polyphenols and an ethanolic extract rich in carotenoids. After drying, the resulting fibre was characterized in terms of chemical composition, soluble and insoluble dietary fibre content and particle size.&nbsp; Technological properties and colour were compared to those of commercial citrus fibre. Energy and time consumption were compared with conventional hot air drying (HAD). Most polyphenols (50-65 %) and limonin (70 %) were extracted during the blanching step. 86 % of carotenoids were removed by soaking in ethanol. The orange fibre obtained had 71.9 g DF/ 100 g and antioxidant properties (205 mg TE/ Kg<sub>dm</sub>). Whiteness, water retention capacity and oil retention capacity were similar to commercial citrus fibre. HAD+MW reduced drying time and energy consumption by up to 50&nbsp;% compared to HAD.</p>

opencc-by-4.0Nov 2021View details →
zenodo40/100

AP-4-mediated axonal transport controls endocannabinoid production in neurons - Imaging data 3

<p>Imaging data associated with Fig. 6c,e,f, 7e-h, S5a,b, S6b-d and S7 from the article &quot;AP-4-mediated axonal transport controls endocannabinoid production in neurons&quot;, published in Nature Communications by Davies et al.</p> <p>DAGLB_Axon_iPSC_derived_neurons:&nbsp;High-throughput confocal imaging was used to assay the density of DAGLB puncta in axons of iPSC neurons from a patient with AP-4 deficiency syndrome (patient 1) and their matched control, labelled with anti-DAGLB, the axonal marker antibody cocktail SMI312 and DAPI.</p> <p>DAGLB_Soma_iPSC_derived_neurons: High-throughput confocal imaging was used to assay the distribution of DAGLB in iPSC-derived neurons from two patients with AP-4 deficiency syndrome (LoF/LoF) and their matched unaffected controls (WT/LoF). Neurons in 96-well plates were labelled with antibodies against DAGLB, GOLGA1 (a TGN marker) and TUJ1, and DAPI. The ratio between the area of high intensity (HI; overlaps with TGN) and low intensity (LI) DAGLB labelling was quantified from three differentiations per cell line.</p> <p>iPSC_derived_neurons_neurite_outgrowth: Neurite outgrowth was assayed in iPSC-derived cortical neurons from two patients with AP4B1-associated AP-4 deficiency syndrome (SPG47) and their unaffected same sex heterozygous parents (control), using automated live cell imaging. Neurons were cultured in the presence of DMSO (vehicle control) or the MGLL inhibitor ABX-1431 at 10, 50, 100 or 500 nM (the highest two doses were administered only to the patient neurons). Neurons were monitored from 4 h post-plating, with images captured every 3 h until 25 h post-plating.</p> <p>See article for methods and further detail.</p>

opencc-by-4.0Nov 2021View details →
zenodo40/100

AP-4-mediated axonal transport controls endocannabinoid production in neurons - Imaging data 2

<p>Imaging data from the article &quot;AP-4-mediated axonal transport controls endocannabinoid production in neurons&quot;, published in Nature Communications by Davies et al., from Fig. 5 and S4.</p> <p>Super resolution structured illumination microscopy (SR-SIM) was used to image HeLa cells expressing endogenously-tagged SERINC1-Clover or SERINC3-Clover, treated with siRNA to knock down AP-4 or non-targeting control siRNA, and labelled with anti-GFP and either anti-ATG9A or anti-DAGLB.</p> <p>SR-SIM was performed on a Zeiss Elyra PS.1 microscope equipped with a 63x/1.46 oil objective (alpha Plan-Apochromat 63x/1.46 Oil Korr M27) and a PCO pco.edge 4.2 sCMOS Camera, and controlled with Zeiss ZEN 2 software with the SR-SIM module. Imaging was performed sequentially, with SERINC1 or SERINC3 (labelled with Alexa Fluor Plus 488) imaged first and DAGLB or ATG9A (labelled with Alexa Fluor 568) imaged second, using 3 rotations of the grid pattern and 5 phases for each rotation. Experiments were performed in biological duplicate, from separate dishes of cells, and with immunofluorescence and microscopy performed independently for each replicate. 20 cells were imaged per condition per replicate, and cell selection and manual focus were performed on the first acquired channel only, without viewing the second channel. For channel alignment, slides with multi-coloured fluorescent beads were imaged before and after each experiment using the same acquisition settings. The data were processed using the SIM module in Zen 2 software in manual mode, using default settings and a theoretical PSF model, except for the following settings: Noise filter -1; SR frequency weighting 2; Max.Isotrop on; Baseline shifted on; Raw scale on. Channel alignment fit parameters were calculated in Zen 2 software using a multi-coloured bead image as input, in affine mode. The resulting parameters were tested on further bead images and then applied to the experimental images. The channel-aligned images were used for colocalisation analysis (see methods of article for details).</p> <p>This dataset includes the raw unprocessed data and the processed and channel aligned input data used for the colocalisation analysis.</p> <p>See article for methods and further detail.</p>

opencc-by-4.0Nov 2021View details →
zenodo40/100

AP-4-mediated axonal transport controls endocannabinoid production in neurons - Imaging data 1

<p>Imaging data from the article &quot;AP-4-mediated axonal transport controls endocannabinoid production in neurons&quot;, published in Nature Communications by Davies et al., from Fig. 2, 3, 4, 6 and S2.</p> <p>Widefield images were captured on a Leica DMi8 inverted microscope equipped with an iTK LMT200 motorised stage, a 63x/1.47 oil objective (HC PL APO 63x/1.47 OIL) and a Leica DFC9000 GTC Camera, and controlled with LAS X (Leica Application Software X).</p> <p>HeLa_HADAGL_RUSC2_Fig_4:&nbsp;Widefield imaging of wild-type HeLa and HeLa cells stably expressing GFP-RUSC2, transiently expressing HA-DAGLB or HA-DAGLA, and labelled with anti-HA (Alexa Fluor 680), anti-ATG9A (Alexa Fluor 568) and DAPI.</p> <p>HeLa_KD_DAGLB_TGN_Fig_S2a,b:&nbsp;Widefield imaging of immunofluorescence double labelling of DAGLB (Alexa Fluor 568) and TGN46 (Alexa Fluor 680) in HeLa cells transfected with a non-targeting siRNA (control) or with siRNA to knock down AP-4. DAPI labelling of the nucleus is also shown. Note, the antibody used to label AP4E1 (Alexa Fluor 488) in replicate 1 had high non-specific background and so was not used in the analysis.</p> <p>HeLa_KO_DAGLB_TGN_Fig_2a,b:&nbsp;Widefield imaging of immunofluorescence double labelling of DAGLB (Alexa Fluor 568) and TGN46 (Alexa Fluor 680) in wild-type, AP4B1 knockout, and AP4B1 knockout HeLa cells stably expressing AP4B1 (functional rescue). DAPI labelling of the nucleus is also shown.</p> <p>HeLa_RUSC2_DAGLB_Fig_3:&nbsp;Widefield imaging of DAGLB (Alexa Fluor 568) labelling in wild-type and AP-4 knockout (AP4B1 KO or AP4E1 KO) HeLa cells, stably expressing GFP-tagged RUSC2. AP4B1 knockout HeLa expressing RUSC2-GFP were also transiently transfected with AP4B1 (rescue) or mock transfected without DNA as a negative control. DAPI labelling of the nucleus is also shown.</p> <p>iPSC_Neurons_DAGLB_TGN_Fig_6a,b:&nbsp;Widefield imaging of immunofluorescence triple labelling of DAGLB (Alexa Fluor 568), TGN46 (Alexa Fluor 680) and TUJ1 (Alexa Fluor 488; a marker to distinguish neurons from co-cultured astrocytes) in iPSC neurons from a patient with AP-4 deficiency syndrome (patient 1) and their matched control.</p> <p>SHSY5Y_DAGLB_TGN_Fig_2c,d_Fig_S2c,d:&nbsp;Widefield imaging of immunofluorescence double labelling of DAGLB (Alexa Fluor 568) and TGN46 (Alexa Fluor 680) in control (parental Cas9-expressing), AP4B1-depleted (BKO) and AP4E1-depleted (EKO) undifferentiated and neuronally-differentiated SH-SY5Y cells. DAPI labelling of the nucleus is also shown.</p> <p>See article for methods and further detail.</p>

opencc-by-4.0Nov 2021View details →
zenodo40/100

PostConsumer r-PET Trials from Bottle&Tray Mix for Foam Board Production

<p>For Armacell, the challenges related to recycling PET tray material are the low intrinsic viscosity (IV), the frequent use of multilayer sheets in packaging trays and other contaminations coming from the mixed plastic household waste collection.</p> <p>To achieve the correct mechanical properties for the PET foam boards, it is essential to limit raw material variations and to master material melt viscosity and pressure in the extruder. With a combination of adapted processing parameters, as well as new melt modifier formulation, it is possible to produce foam boards from tray-PET that have a comparable quality to foam boards produced from bottle PET.</p> <p>Attached, different properties and results from the tested postconsumer material and the foam board produced are presented sown to the H2020 PlastiCircle Project.</p>

opencc-by-4.0Apr 2021View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.